Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions GlobeNewswire December 01, 2025 BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — Neuphoria Therapeutics Inc. (“Neuphoria” or the “Company”) (NASDAQ: NEUP), a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders, today issued the following […]